0000935836-23-000741.txt : 20231227
0000935836-23-000741.hdr.sgml : 20231227
20231227160425
ACCESSION NUMBER: 0000935836-23-000741
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231218
FILED AS OF DATE: 20231227
DATE AS OF CHANGE: 20231227
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Capital, LLC
CENTRAL INDEX KEY: 0001587114
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35921
FILM NUMBER: 231517977
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Mirati Therapeutics, Inc.
CENTRAL INDEX KEY: 0001576263
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 462693615
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-332-3410
MAIL ADDRESS:
STREET 1: 3545 CRAY COURT
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
3
1
ownership.xml
X0206
3
2023-12-18
0
0001576263
Mirati Therapeutics, Inc.
MRTX
0001587114
EcoR1 Capital, LLC
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
0
0
1
0
Common Stock
7396979
I
See Note
The filing persons (the "Filers") are EcoR1 Capital, LLC ("EcoR1") and Oleg Nodelman. EcoR1 is the general partner and investment adviser of private funds (collectively, the "Funds"). Mr. Nodelman is the manager and controlling owner of EcoR1. EcoR1 is filing this Form 3 for itself and Mr. Nodelman. The Filers are filing this Form 3 jointly, but not as a group, and each expressly disclaims membership in a group, within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. The Funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the Funds, and Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Filers disclaim beneficial ownership of such securities except to the extent of their respective pecuniary interests therein.
/s/ Oleg Nodelman, Manager of EcoR1 Capital, LLC
2023-12-27